Opioid agonist treatment and patient outcomes during the COVID-19 pandemic in south east Sydney, Australia

Original research
par
Lintzeris, Nicholas et al

Date de publication

2021

Géographie

Australia

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

L’objectif

Describes Covid-related changed to treatment & preliminary analysis of the association with patients' substance use and well-being.

Constatations/points à retenir

These preliminary findings suggest that the modified model of care continued to provide safe and effective treatment, during the pandemic. Notably, there was no association between more TAD and significant increases in substance use.

La conception ou méthodologie de recherche

n=429 A pre-post comparison of treatment conditions and patient self-reported outcomes using data extracted from electronic medical records in the 5 months before (December 2019–April 2020) and after (May 2020–September 2020) changes were implemented in three public treatment services in South Eastern Sydney Local Health District.

Mots clés

Evidence base
Harm reduction
Safer supply
Advocacy
About prescribers
Outcomes